Le Lézard
Classified in: Oil industry, Science and technology, Business
Subject: CON

Lummus to Provide Digital Solutions to Haldia Petrochemicals


Lummus' first award for O3Stm digital services in India; Digitalization will enhance operations and plant performance for long-time customer.

HOUSTON, May 2, 2024 /PRNewswire/ -- Lummus Technology, a global provider of process technologies and value-driven energy solutions, announced it has been awarded a contract by Haldia Petrochemicals Ltd. (HPL) for digitalization services at HPL's ethylene plant in West Bengal, India.

"For more than two decades, we have collaborated with HPL and provided them with best-in-class process technologies," said Ujjal Mukherjee, Chief Technology Officer, Lummus Technology. "This latest award showcases our integrated offering where we provide technologies and other solutions throughout the life cycle of a plant. HPL will be able to leverage Lummus' proprietary know-how, process expertise and digital solutions to enhance the plant for peak performance and optimize OPEX."

The award is Lummus' first O3Stm award in India. Lummus will provide its digitalization, training and knowledge transfer services for HPL's ethylene plant. Previously, Lummus was awarded a contract for the license and basic engineering for the same unit, which builds on the 25-plus years HPL has licensed Lummus' technologies for its operations.

O3Stm is part of a broad array of training and digitalization services Lummus provides to licensees to meet specific and individual requirements. These services include hands-on opportunities to simulate plant operation, which enables operational teams to run the plant in a safer, more productive way, leading to better performance, higher efficiency and less waste.

About Lummus Technology 
Lummus Technology is the global leader in developing technology solutions that make modern life possible and focus on a more sustainable, low carbon future. We license process technologies in clean fuels, renewables, petrochemicals, polymers, gas processing and supply lifecycle services, catalysts, proprietary equipment and digitalization to customers worldwide. To learn more about Lummus, visit www.LummusTechnology.com.

SOURCE Lummus Technology, LLC


These press releases may also interest you

at 06:02
Weekly Recap: 11 Press Releases You Might Have Missed
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major...

at 06:00
Amplify10 Unveils Groundbreaking AI-Powered Sales Execution Platform, Revolutionizing Enterprise Sales Performance
Amplify10, the trailblazer in SaaS AI-Powered Sales Execution solutions, proudly announces its official launch today, aimed at reshaping the landscape of sales performance for enterprises worldwide. The early-stage company, formerly known as...

at 06:00
Quhuo Announces Changes to Board of Directors
Quhuo Limited ("Quhuo" or the "Company") , a leading gig economy platform focusing on local life services in China, today announced that Ms. Chenxi Zhao has resigned from her position as a member of the board of directors (the "Board"), effective on...

at 05:50
NADclinic and Bontac Bio-Engineering (Shenzhen) Co., Ltd Announce Strategic Partnership to Evolve the Future of Global Wellness Through the Power of NAD+
NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic strategic partnership to collaboratively focus on the future of global health and wellness. Synergistically leveraging their collective expertise...

at 05:45
China Duty Free Group outlines growth strategy at TFWA Asia Pacific Conference
A report from China.org.cn:  China Duty Free Group (CDFG), the world's leading travel retail operator, outlined its strategy for continued growth at the recently concluded TFWA Asia Pacific Exhibition & Conference held in Singapore from May 12 to...

at 05:35
Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1b Initiation for ALPK1 Selective Kinase Inhibitor, DF-003 in ROSAH Syndrome Patients
Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1) inhibitor for clinical evaluation in...

More news about Science and technology...


News published on and distributed by: